» Download Public Reports
About 100 reports
- Company report
- January 2013
- 5 pages
- by Research Paper
... prescription drug benefit when congress was debating the medicare drug benefit in 2003, there were many who advocated that medicare provide the benefit as part of the trional hospital insurance program ...
January 2013
... Such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti's lead prescription drug cand is capre , a purified high omega-3 phospholipid ...
January 2013
... Biopharm ), In which neptune respectively holds 57% and 96% of the voting rights, neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and neurobiopharm respectively focus ...
March 2013
... Equal to 0.1%. This is significantly lower than the low end of the ow recommended range for prescription drug trend, as described in the 3q13-4q13 epo/ppo small group filing, which is 8 ...
April 2013
... A novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of trional, high dose prescription drugs. The company is developing ...
April 2013
... Key terminology prescription drug plan (pdp)-insurance plan used to cover prescription drugs as part of medicare part d Doughnut hole-point at which pdp stops offering coverage ...
January 2013
... prescription drugs no cost up to $1,500 per person per year thereafter, you pay 20% coinsurance up to the annual out- of-pocket maximum no preventive prescription allowance other prescription drugs you pay ...